Browse > Article

Suppression of Adiposity and Improvement of Fat Metabolism in High-fat Diet-induced Obese Mice Treated with an Inonotus obliquus Extract  

Kim, Bobae (School of Life Science, Handong Global University)
Kim, Min-Seok (School of Life Science, Handong Global University)
Hyun, Chang-Kee (School of Life Science, Handong Global University)
Publication Information
Korean Journal of Pharmacognosy / v.47, no.2, 2016 , pp. 172-178 More about this Journal
Abstract
Using high-fat diet-induced obese (DIO) mice, the mechanism of anti-adiposity and anti-obesity actions produced by Inonotus obliquus water extract (IOE) was investigated. Significant reduction in body weight in DIO mice orally administrated with IOE for 8 weeks compared to IOE-non-treated control mice was observed, which was attributed to the reduction of epididymal and mesenteric adipose tissue, but not the liver and skeletal muscle. Adiponectin synthesis in epididymal adipose tissue (EAT) and AMPK phosphorylation in the liver were significantly increased in IOE-treated DIO mice. Gene expression analysis showed that IOE-treated DIO mice had higher expression levels of lipogenic genes in EAT and fatty-acid oxidative genes in the liver, but lower expression levels of hepatic pro-inflammatory cytokines compared to IOE-non-treated controls. Our findings confirm a therapeutic potential of Inonotus obliquus for reducing adiposity and ameliorating hyperlipidemia to treat metabolic disorders.
Keywords
Inonotus obliquus; Diet-induced obesity; Anti-obesity; Adiponectin; AMPK; Fat metabolism;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C. Jr., Spertus, J. A. and Costa, F. (2005) Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112: 2735-2752.   DOI
2 Korea Centers for Disease Control and Prevention (2014) Korea National Health and Nutrition Examination Survey, www.cdc.go.kr.
3 Kim, J. B. (2016) Dynamic cross talk between metabolic organs in obesity and metabolic diseases. Exp. Mol. Med. 48: 1-2.
4 Browning, J. D. and Horton, J. D. (2013) Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114: 147-152.
5 Mizuno, T., Zhuang, C., Abe, K., Okamoto, H., Kiho, T., Ukai, S., LeClerc, S. and Meijer, L. (1999) Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus. Int. J. Med. Mushrooms. 1: 301-316.   DOI
6 Sun, J. E., Ao, Z. H., Lu, Z. M., Xu, H. Y., Zhang, X. M., Dou, W. F. and Xu, Z. H. (2008) Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J. Ethnopharmacol. 118: 7-13.   DOI
7 Kim, M. A., Jeong, Y. S., Chun, G. T. and Cha, Y. S. (2009) Antihyperlipidemic and glycemic control effects of mycelia of Inonotus obliquus including protein-bound polysaccharides extract in C57BL/6J mice. J. Kor. Soc. Food Sci. Nutr. 38: 667-673.   DOI
8 Lee, J. H. and Hyun, C. K. (2014) Insulin-sensitizing and beneficial lipid-metabolic effects of the water-soluble melanin complex extracted from Inonotus obliquus. Phytother Res. 28: 1320-1328.   DOI
9 Cui, Y., Kim, D. S. and Park, K. C. (2005) Antioxidant effect of Inonotus obliquus. J. Ethnopharmacol. 96: 79-85.   DOI
10 Kim, Y. O., Han, S. B., Lee, H. W., Ahn, H. J., Yoon, Y. D., Jung, J. K., Kim, H. M. and Shin, C. S. (2005) Immuno-stimulating effect of the crude-polysaccharide produced by submerged culture of Inonotus obliquus. Life Sci. 77: 2438-2456.   DOI
11 Song, Y., Hui, J., Kou, W., Xin, R., Jia, F., Wang, N., Hu, F., Zhang, H. and Liu, H. (2008) Identification of Inonotus obliquus and analysis of antioxidation and antitumor activities of polysaccharides. Curr. Microbiol. 57: 454-462.   DOI
12 Cariou, B., Charbonnel, B. and Staels, B. (2012) Thiazolidinediones and $PPAR{\gamma}$ agonists - time for a reassessment. Trends Endocrinol. Metab. 23: 205-215.   DOI
13 Wendel, A. A., Lewin, T. M. and Coleman, R. A. (2009) Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis. Biochim. Biophys. Acta. 1791: 501-506.   DOI
14 Nigro, E., Scudiero, O., Monaco, M. L., Palmieri, A., Mazzarella, G., Costagliola, C., Bianco, A. and Daniele, A. (2014) New insight into adiponectin role in obesity and obesityrelated diseases. Biomed. Res. Int. 2014: 1-14.
15 Rasouli, N. and Kern, P. A. (2008) Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 93: S64-S73.   DOI
16 Jung, U. J. and Choi, M. S. (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 15: 6184-6223.   DOI
17 You, M., Considine, R. V., Leone, T. C., Kelly, D. P. and Crabb D. W. (2005) The role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42: 568-577.   DOI
18 Patel, P. S., Buras, E. D. and Balasubramanyam, A. (2013) The role of the immune system in obesity and insulin resistance. J. Obes. 2013: 616193.